KLF4 suppresses transformation of pre-B cells by ABL oncogenes

Michael G Kharas1, Isharat Yusuf, Vanessa M Scarfone

  • 1Department of Molecular Biology and Biochemistry, University of California-Irvine, 3242 McGaugh Hall, Irvine, CA 92697-3900, USA.

Blood
|September 7, 2006
PubMed

Insights

Krüppel-like factor 4 (KLF4) suppresses B-cell leukemia by inducing cell cycle arrest and apoptosis. KLF4 acts as a tumor suppressor, blocking oncogene-driven transformation and depleting leukemic cells in vivo.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Hematology

Background:

  • Genes repressed during B-cell activation are implicated in B-cell malignancies.
  • Krüppel-like factor 4 (KLF4) is downregulated in activated B cells and expressed at low levels in B-cell lymphomas and leukemias.
  • KLF4 functions as a tumor suppressor in epithelial cancers, inhibiting proliferation.

Purpose of the Study:

  • To investigate the role of KLF4 in pro/pre-B-cell transformation induced by v-Abl and BCR-ABL oncogenes.
  • To determine the effects of KLF4 on cell cycle progression, apoptosis, and oncogene-driven leukemogenesis.

Main Methods:

  • Overexpression of KLF4 in pro/pre-B cells and analysis of cell cycle phase and apoptosis.
  • Assessment of KLF4's impact on key cell cycle regulators (p21CIP, c-Myc, cyclin D2).
  • Utilizing tetracycline-inducible KLF4 expression in transgenic mouse models with BCR-ABL-induced leukemia.

Main Results:

  • KLF4 overexpression induces G1 cell cycle arrest and apoptosis in transformed pro/pre-B cells.
  • KLF4-induced apoptosis is partially rescued by Bcl-XL, while cell cycle arrest is not.
  • KLF4 upregulates p21CIP and downregulates c-Myc and cyclin D2, inhibiting transformation and depleting leukemic cells in vivo.

Conclusions:

  • KLF4 functions as a tumor suppressor in B-cell malignancies.
  • KLF4 inhibits BCR-ABL-driven leukemogenesis by inducing cell cycle arrest and apoptosis.
  • KLF4 represents a potential therapeutic target for B-cell leukemias and lymphomas.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...